secwatch.observer — SEC 8-K summary
======================================

Issuer:     HYPERION DEFI, INC. (HYPD)
CIK:        0001682639
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001104659-24-061954
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eyenovia Q1 net loss $10.9M, up from $5.7M; advances MicroPine and clobetasol pipeline
--------------------------------------------------------------------------------

- Net loss Q1 2024 $10.9M ($0.23/shr) vs $5.7M ($0.15/shr) in Q1 2023; includes $2.5M charge for MicroPine license reacquisition.
- R&D expenses $4.4M (+75.7% YoY), G&A $3.8M (+30.6% YoY); total operating expenses $10.3M (+88.1% YoY).
- Cash and equivalents $8.0M at March 31, 2024; additional $2.2M raised in April 2024.
- MicroPine Phase 3 CHAPERONE DMC review planned for early Q4 2024; clobetasol launch targeted for Q3 2024.
- Mydcombi rollout: 50 new offices trained; reduced cash expenses by ~$0.8M per quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682639/000110465924061954/0001104659-24-061954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682639/000110465924061954/tm2414361d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-061954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer